Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maxheal Laboratories is a prominent Indian pharmaceutical company specializing in the development, manufacturing, and global distribution of generic finished dosage forms. Founded in 1984, the company operates WHO-GMP certified manufacturing facilities in Nashik, producing a wide array of therapeutic products including anti-infectives, cardiovascular agents, and gastrointestinal medications. Maxheal maintains a strong international presence, exporting to over 40 countries across Africa, Southeast Asia, and Latin America. In addition to its proprietary brand portfolio, the company serves as a contract development and manufacturing organization (CDMO) for various global pharmaceutical partners. Their product range encompasses diverse delivery formats such as tablets, capsules, liquid orals, and topical ointments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maxheal Laboratories.